+1 201 316 9200
+81 (0)3 6264 0600
Europe & Rest of World
+41 61 316 81 11
Reach Our Protein Experts:
The Applied Protein Services (APS) platform is effective at improving the developablity and manufacturability: quality, safety, and efficacy of antibodies, therapeutic proteins, peptides and vaccines. By supporting the successful risk assessment, selection, optimization and early process development of promising drug candidates, Lonza’s Applied Protein Services improves your likelihood of hitting your target each time.
We offer a complete line of in silico and in vitro services for developability, immunogenicity, stability, humanization, and protein engineering. These technologies include our award winning and patented Epibase™ T cell epitope screening platform along with our proprietary technology platform for structural protein engineering.
To learn more about a therapeutic protein's journey through the immune pathway, watch our Immunogenicity Services video.
To read more about our in silico and in vitro platforms, download our Developability and Immunogenicity Assessment Services brochures.
APS Product Applications:
Discovery Phase Material Supply Services (mg to kg)
Our goal at Lonza is to offer you a complete service portfolio for your early discovery and development needs. In addition to our full range of protein analysis services, we also offer a new custom supply service for mg to kg quantities of both GMP and non-GMP material.
The new streamlined and minimal scope development and manufacturing services, called Light Path™, are available for both mammalian and microbial applications. Light Path™ programs have been designed by our Mammalian R&D Services experts who have used their years of experience and optimization to create a set of minimal scope processes to achieve your early project goals.